Dermatologic Therapy

Article	Citations
Oral manifestations ofCOVID‐19 disease: A review article	163
COVID‐19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi‐center, real‐life, telemedical, and observational prospective study	70
Evaluation of skin problems and dermatology life quality index in health care workers who use personal protection measures during COVID ‐19 pandemic	53
The impact of air pollution on skin and related disorders: A comprehensive review	51
Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate‐to‐severe atopic dermatitis: A network meta‐analysis	50
Telogen effluvium associated with COVID‐19 infection	46
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti‐ interleukin ‐17 treatment: A real‐life 52‐week retrospective study	45
Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study	42
Cutaneous adverse reactions after COVID‐19 vaccines in a cohort of 2740 Italian subjects: An observational study	42
Drug survival in the treatment of generalized pustular psoriasis: A retrospective multicenter study	42
COVID‐19 and exacerbation of dermatological diseases: A review of the available literature	37
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting	36
COVID ‐19 vaccine‐induced urticarial vasculitis	36
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study	35
Evaluating hyaluronic acid dermal fillers: A critique of current characterization methods	35
Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence	34
Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report	33
Efficacy of resveratrol in the wound healing process by reducing oxidative stress and promoting fibroblast cell proliferation and migration	33
Recurrent aphthous stomatitis: A comprehensive review and recommendations on therapeutic options	32
Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience	32
Psoriasis flare after influenza vaccination in Covid‐19 era: A report of four cases from a single center	32
Onset of vitiligo in a psoriasis patient on ixekizumab	32
Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real‐life study	32
Cutaneous manifestations following COVID‐19 vaccination: A report of 25 cases	31
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine	31

Emerging role of anti‐IL23 in the treatment of psoriasis: When humanized is very promising	31
Possible association between IgA vasculitis and COVID ‐19	31
JAK‐inhibitors for dermatomyositis: A concise literature review	30
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?	30
Systematic review of platelet‐rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability	30
Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors	30
“Covid arm”: Abnormal side effect after Moderna COVID ‐19 vaccine	30
A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders	30
Increased risk of late‐onset, immune‐mediated, adverse reactions related to dermal fillers in patients bearing HLA‐B *08 and DRB1	29
Sudden onset of vitiligo after COVID‐19 vaccine	29
COVID ‐19 from the perspective of dentists: A case report and brief review of more than 170 cases	29
Cause and management of lipedema‐associated pain	29
The use of human acellular dermal matrices in advanced wound healing and surgical procedures: State of the art	28
Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry	28
Systematic review of low‐dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies	28
Mask‐induced Koebner phenomenon and its clinical phenotypes: A multicenter, real‐life study focusing on 873 dermatological consultations during COVID‐19 pandemics	28
Pityriasis rosea after Moderna mRNA ‐1273 vaccine: A case series	27
Management of urticaria in COVID ‐19 patients: A systematic review	27
Cutaneous adverse reactions of COVID ‐19 vaccines: A systematic review	27
Acne treatment review and future perspectives	27
Guselkumab: Mid‐term effectiveness, drug survival, and safety in real clinical practice	27
COVID‐19 induced telogen effluvium	27
The efficacy of energy‐based devices combination therapy for melasma	27
Subacute cutaneous lupus erythematosus flare triggered by COVID‐19 vaccine	27
Effectiveness of anti‐interleukin 23 biologic drugs in psoriasis patients who failed anti‐interleukin 17 regimens. A real‐life experience	27
New‐onset lichen planus arising after COVID‐19 vaccination	26
Pityriasis rosea‐like cutaneous eruption as a possible dermatological manifestation after Oxford‐AstraZeneca vaccine: Case report and brief literature review	26
Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis	26
SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review	25
The clinical utility of teledermoscopy in the era of telemedicine	25
Treatments for alopecia areata: A systematic review and network meta‐analysis	25
Aphthous stomatitis in COVID ‐19 patients: Case‐series and literature review	25
Tumor necrosis factor inhibitors are associated with a decreased risk ofCOVID‐19‐associated hospitalization in patients with psoriasis—A population‐based cohort study	25
Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review	24
Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study	24
Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant)	24
Disease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis	24
Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases	24
The efficacy of fractional CO 2 laser in acne scar treatment: A meta‐analysis	23
Onset/flare of psoriasis following the ChAdOx1 nCoV ‐19 Corona virus vaccine ( Oxford‐AstraZeneca /Covishield): Report of two case	23
Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis	23
Cutaneous adverse events related to COVID ‐19 vaccines: A cross‐sectional questionnaire‐based study of 867 patients	23
Multicenter study evaluating the impact of COVID ‐19 outbreak on dermatology outpatients in Turkey	23
Laser tattoo removal: Fundamental principles and practical approach	23
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16‐week real‐life experience during the COVID ‐19 pandemic in Italy	23
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus	23
New emergent therapies for atopic dermatitis: A review of safety profile with respect to female fertility, pregnancy, and breastfeeding	22
NB‐UVB plus oral Polypodium leucotomos extract display higher efficacy than NB‐UVB alone in patients with vitiligo	22
Alopecia areata in a COVID‐19 patient: A case report	22
Platelet‐rich plasma—Where do we stand today? A critical narrative review and analysis	22

Topical treatment for plantar warts: A systematic review	22
Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female	22
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection	21
A systematic review on treatment‐related mucocutaneous reactions in COVID ‐19 patients	21
The manifestation of oral mucositis in COVID ‐19 patients: A case‐series	21
A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial	21
Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report	21
A 24‐weeks real‐world experience of dupilumab in adolescents with moderate‐to‐severe atopic dermatitis	21
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication	21
Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib	20
Natural products for male androgenetic alopecia	20
Tapinarof for the treatment of psoriasis	20
Maculopapular skin eruptions associated with Covid‐19: A systematic review	20
Contact dermatitis due to masks and respirators during COVID ‐19 pandemic: What we should know and what we should do	20
Topicalbeta‐blockersin dermatologic therapy	20
Dimethyl fumarate treatment for psoriasis in a real‐life setting: A multicentric retrospective study	19
Tetracyclines in COVID ‐19 patients quarantined at home: Literature evidence supporting real‐world data from a multicenter observa	19
Lichen planus and lichen planopilaris flare after COVID ‐19 vaccination	19
Topical dermocosmetics and acne vulgaris	19
Challenges in sarcoidosis and sarcoid‐like reactions associated to immune checkpoint inhibitors: A narrative review apropos of a case	19
Patient‐reported outcomes of topical therapies in actinic keratosis: A systematic review	19
Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options	19
Exacerbation of psoriasis following COVID ‐19 vaccination in a patient previously treated with PD ‐1 inhibitor	18
Surveillance of psoriatic patients on biologic treatment during the COVID‐19 pandemic: A single‐center experience	18
Pustular psoriasis exacerbated by COVID ‐19 in a patient with the history of psoriasis	18
Activation of Janus kinase signaling pathway in acne lesions	18
Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study	18
Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria	18
Emerging off‐label esthetic uses of botulinum toxin in dermatology	18
Post Covid‐19 vaccination papulovesicular pityriasis rosea‐like eruption in a young male	18
Oral cyclosporine is effective in stabilizing active vitiligo: Results of a randomized controlled trial	18
A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study	18
Cutaneous lymphocytic vasculitis after administration of COVID ‐19 mRNA vaccine	18
Evaluation of the laboratory parameters in hidradenitis suppurativa: Can we use new inflammatory biomarkers?	18
Effectiveness and safety of guselkumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group	18
Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity	18
Dupilumab combined with low‐dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid	17
Risankizumab shows high efficacy and maintenance in improvement of response until week 52	17
Amelioration of dystrophic epidermolysis bullosa pruriginosa symptoms with dupilumab: A case report	17
Ustekinumab for the treatment of paradoxical skin reactions and cutaneous manifestations of inflammatory bowel diseases	17
Dermatological findings in patients admitting to dermatology clinic after using face masks during Covid‐19 pandemia: A new health problem	17
Different hair loss patterns in two pediatric patients with COVID‐19‐associated multisystem inflammatory syndrome in children	17
Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐ to‐treat disease or a consequence of late rituximab initiation?	17
Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo‐controlled trial	17
Combination therapy of refractory keloid with ultrapulse fractional carbon dioxide (CO2) laser and topical triamcinolone in Asians‐long‐termprevention of keloid recurr	17
Immunosuppressive drugs for patients with psoriasis during the COVID ‐19 pandemic era. A review	17
Teledermatology during the COVID ‐19 pandemic: Experience at a tertiary care centre in North India	17
The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions	16
Does therapy with biological drugs influence COVID ‐19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic pa	16
Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth	16
Autologous intralesional platelet rich plasma improves melasma	16
Oral nicotinamide: The role in skin cancer chemoprevention	16
Generalized pustular psoriasis following COVID ‐19	16
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review	16
Acute localized exanthematous pustulosis: Clinical features, pathophysiology, and therapy	16
A randomized, controlled, split‐face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea	16
Noninvasive diagnostic techniques in the preoperative setting of Mohs micrographic surgery: A review of the literature	16
An updated review of the sebaceous gland and its role in health and diseases Part 1: Embryology, evolution, structure, and function of sebaceous glands	16
Guselkumab in the treatment of severe hidradenitis suppurativa, a promising role?	16
Safety of SARS‐CoV‐2 vaccines in psoriatic patients treated with biologics: A real life experience	16
IL‐17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review	16
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review	16
Livedoid vasculopathy in 75 Brazilian patients in a single‐center institution: Clinical, histopathological and therapy evaluation	16
Photothermal therapy using gold nanoparticles for acne in Asian patients: A preliminary study	16
Hair‐pulling disorder (Trichotillomania): Etiopathogenesis, diagnosis and treatment in a nutshell	16
The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons	15
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild‐to‐moderate hidradenitis suppurativa: A retrospective study	15
Is chemoprophylaxis necessary for all latent tuberculosis infection patients receivingIL‐17 inhibitors? A cohort study	15
Bullous pemphigoid triggered by COVID ‐19 vaccine: Rapid resolution with corticosteroid therapy	15
Latest combination therapies in psoriasis: Narrative review of the literature	15
Outcomes and adverse effects of ablative vs nonablative lasers for skin resurfacing: A systematic review of 1093 patients	15
Dermatomyositis following COVID ‐19 vaccination	15
Vascularization and fibrosis are important ultrasonographic tools for assessing response to adalimumab in hidradenitis suppurativa: Prospective study of 32 patients	15
Most worthwhile superficial chemical peel for melasma of skin of color: Authors' experience of glycolic, trichloroacetic acid, and lactic peel	15
Losartan treatment improves recessive dystrophic epidermolysis bullosa: A case series	15
Applications of microneedling for various dermatologic indications with a special focus on pigmentary disorders: A comprehensive review study	15
Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa	15
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID‐19	15
The impact of COVID ‐19 in patients with psoriasis: A multicenter study in Istanbul	15
Efficacy and safety of Risankizumab in moderate to severe psoriasis: A systematic review and meta‐analysis	15

Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article	15
Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID ‐19 vaccine: A report of three cases	14
Ostomy 101 for dermatologists: Managing peristomal skin diseases	14
Tetracyclines and photosensitive skin reactions: A narrative review	14
Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series	14
Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID‐19 pandemic: Insights from Google Trends	14
Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real‐world clinical practice	14
Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID‐19 pandemic	14
A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo	14
Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies	14
Are biologics combined with methotrexate better than biologics monotherapy in psoriasis and psoriatic arthritis: A meta‐analysis of randomized controlled trials	14
Laser therapy in cutaneous and genital warts: A review article	14
Aggressive course of pemphigus vulgaris followingCOVID‐19 infection	14
New‐onset bullous pemphigoid after inactivated Covid‐19 vaccine: Synergistic effect of the Covid‐19 vaccine and vildagliptin	14
Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex‐specific differences in psoriasis in the Czech Republic	14
Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans	13
Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti‐TNF and anti‐interleukin‐17 failures	13
Dupilumab‐induced psoriasis in a patient with atopic dermatitis and alopecia totalis: A case report and literature review	13
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis	13
Pemphigus vulgaris after SARS‐CoV ‐2 vaccination: A case with new‐onset and two cases with severe aggravation	13
Effectiveness of baricitinib in prurigo‐type atopic dermatitis: A case report	13
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review	13
The evaluation of efficacy of atmospheric pressure plasma in diabetic ulcers healing: A randomized clinical trial	13
An extremely rare mucocutaneous adverse reaction following COVID ‐19 vaccination: Toxic epidermal necrolysis	13
Identification of differentially expressed circular RNAs in keloid and normal skin tissue by high‐throughput sequencing	13
Successful treatment of refractory prurigo nodularis with baricitinib	13
Drugs associated with development of porokeratosis: A systematic review	13
Successful therapy of disseminated patch‐type granuloma annulare with upadacitinib in a patient with rheumatoid arthritis	13
A randomized clinical trial on therapeutic effects of 0.25 mg oral minoxidil tablets on treatment of female pattern hair loss	12
How good is artificial intelligence (AI) at solving hairy problems? A review of AI applications in hair restoration and hair disorders	12
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib	12
Increase and consequences of self‐medication in dermatology during COVID ‐19 pandemic: An initial observation	12
The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss	12
Immunopathogenesis and management of polymorphic light eruption	12
Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review	12
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real‐life data from a multicenter observational study focusing on elderly patients	12
Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration	12
Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis	12
Vitamin E supplementation in inflammatory skin diseases	12
Successful use of anti‐IL ‐23 molecules in overweight‐to‐obese psoriatic patients: A multicentric retrospective study	12
Urticaria relapse after mRNA COVID ‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐cente	12
Patient with atopic dermatitis, hyper IgE syndrome and ulcerative colitis, treated successfully with dupilumab during pregnancy	12
Rivaroxaban for treatment of livedoid vasculopathy: A systematic review	12
Hyperdiluted calcium hydroxylapatite for the treatment of skin laxity of the neck	12
A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet‐rich plasma in patchy alopecia areata of the scalp	12
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?	12
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID ‐19 pandemic?	11
COVID ‐19 vaccines: What dermatologists should know?	11
Platelet‐rich plasma versus carboxytherapy for the treatment of periocular hyperpigmentation; which approach is superior?	11
Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 in	11
A prospective, randomized clinical study to compare the efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller in autologous noncultured epidermal cell suspension in s	11
Treatment of superficial basal cell carcinoma with 7.8% 5‐aminolaevulinic acid nanoemulsion‐based gel ( BF ‐200 ALA ) and photodyn	11
Transverse orange nail lesions following SARS‐CoV ‐2 infection	11
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italia	11
Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report	11
Intralesional methotrexate in dermatology: Diverse indications and practical considerations	11
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real‐life multicenter prospective ob	11
Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib	11
Effect of platelet‐rich plasma on the outcome of mini‐punch grafting procedure in localized stable vitiligo: Clinical evaluation and relation to lesional basic fibroblast growth factor	11
Nails and COVID ‐19 – A comprehensive review of clinical findings and treatment	11
Increased risk of subclinical atherosclerosis and metabolic syndrome in patients with vitiligo: a real association or a coincidence?	11
Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2	11
Three‐year U.S. pharmacovigilance report of brodalumab	11
Combined autologous platelet‐rich plasma with microneedling versus microneedling with non‐cross‐linked hyaluronic acid in the treatment of atrophic acne scars: Split	11
Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective	11
Vaccine‐induced dermatomyositis following COVID ‐19 vaccination	11
A case of new‐onset acute generalized pustular psoriasis following Pfizer‐BioNTech COVID ‐19 vaccine	11
	11
Mycophenolate mofetil treatment of an H syndrome patient with a SLC29A3 mutation	11
Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens	11
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa	11
A clinical, dermoscopic, histopathological and immunohistochemical study of melasma and facial pigmentary demarcation lines in the skin of color	11
Leukocytoclastic vasculitis after COVID ‐19 vaccination	10
New onset of psoriasis following COVID ‐19 vaccination	10
How to assess patient satisfaction regarding physician interaction: A systematic review	10
Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID ‐19 pandemic: The real‐world experience of a single center	10
Intralesional immunotherapy for molluscum contagiosum: A review	10
Tofacitinib in resistant chronic actinic dermatitis: A case series	10
An overview on the role of CO 2 laser in general dermatology	10
Efficacy and safety profile of antioxidants in the treatment of atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials	10
Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis	10
Challenges in the treatment of a patient with toxic epidermal necrolysis associated with COVID ‐19: A case report	10
Adverse skin reactions to personal protective equipment during COVID‐19 pandemic in Italian health care workers	10
The role of topical timolol in wound healing and the treatment of vascular lesions: A narrative review	10
Serum YKL ‐40 and IL 17 in Psoriasis: Reliability as prognostic markers for disease severity and responsiveness to treatment	10
Sonidegib after vismodegib discontinuation in a patient with Gorlin–Goltz syndrome and multiple basal cell carcinomas	10
Effectiveness of brodalumab after previous treatment failure of interleukin‐17A inhibitors in patients with psoriasis	10
Management of pernio‐like cutaneous manifestations in children during the outbreak of COVID‐19	10
A case of lichen amyloidosis associated with atopic dermatitis successfully treated with dupilumab: A case report and literature review	10
Significant improvement in body contour with multiple cycles of CoolSculpting: Results of a prospective study	10
Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA ( EffeCtiveness of biologi	10
Rituximab as the treatment of pemphigus vulgaris in the COVID ‐19 pandemic era: A narrative review	10
Dapsone in hidradenitis suppurativa: A case series of 56 patients	10
Urticarial vasculitis following mRNA anti‐COVID ‐19 vaccine	10
Comparison of overall efficacy and safety of oral versus subcutaneous methotrexate in severe psoriasis	10